Drawing for NIZHONI

USPTO serial 86622951

NIZHONI

Reviewed by CopyMark Law Group

Reg. 5028089Status 710
Filing date
Status date
Registration date
Aug 23, 2016
Examiner
SALEMI, DOMINICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NIZHONI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacey C. Friends

Stacey C. Friends Ruberto, Israel & Weiner, P.C.255 State Street. 7th FloorBoston, MA 02109UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Consulting services to health care providers in the field of treating life-changing or life-threatening diseases and illnesses; geriatric health care management services; health care services, namely, disease management programs; health care services, namely, providing a database in the field of psychiatric and medical disorders, chronic disease conditions, alcohol, substance abuse or addictions, eating disorders, dementia and traumatic brain injury, spinal cord injury, Alzheimer's disease, seizure disorders, neurological conditions, including aftercare of the late effect CVA clients; health care services for pulmonary and respiratory disorders; malignancies and cancers, end-of-life care; health care services for metabolic disorders including, diabetes, thyroid and pancreatic disease processes and genetic anomalies; health care services for treating and managing cardiovascular disorders as well as any arteria and venous conditions, hematologic disorders, gastrointestinal and genitourinary disorders, musculo-skeletal disorders, skin disorders and/or breakdown with subsequent infectious processes; health care services for caring for clients with HIV and AIDS and or other immune-suppressed and immune compromised individuals; health care services for caring for individuals who are status-post organ transplants or dialysis clients; health care services for caring for individuals with eye disorders/impairments including glaucoma, cataracts or blindness who may have additional diagnoses that require home health care services; health care services for caring for individuals with vision disorders and impairments including glaucoma, cataracts or blindness who may have additional diagnoses that require home health care services; health care services for individuals with acquired antibiotic-resistant infections, or those who require home PT/INR monitoring for anticoagulation therapy, information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; health care services for treating and managing psychiatric and medical disorders, both acute as well as chronic disease conditions including psychiatric disorders which include thought, mood and personality disorders, assessment and treatment for depression, alcohol or other substance abuse or addictions, eating disorders, dementia and traumatic brain injury/spinal cord injury, Alzheimer's disease, seizure disorders, as well as any cognitive components, and all neurological conditions, including aftercare of the late effect CVA client; health care services for treating and managing pulmonary and respiratory disorders including, asthma, chronic obstructive pulmonary disease, upper respiratory infections and disease processes, malignancies and cancers, including end-of-life care; health care services for metabolic disorders including, diabetes, thyroid and pancreatic disease processes and genetic anomalies; health care services for treating and managing cardiovascular disorders as well as any arterial/venous conditions, hematologic disorders, gastrointestinal and genitourinary disorders, musculo-skeletal disorders, skin disorders and/or breakdown with subsequent infectious processes; health care services for treating and managing individuals with HIV and AIDS, or other immune-suppressed/compromised individuals, health care services for treating and managing individuals status-post organ transplants or dialysis clients, and/or individuals with eye/vision disorders/impairments, including glaucoma, cataracts or blindness who may have additional diagnoses that require home health care services; health care services for treating and managing individuals with acquired antibiotic-resistant infections, or those who require home PT/INR monitoring for anticoagulation therapy; health care services offered through a network of health care providers on a contract basis; health care services, namely, geriatric health care; health care services for pain assessment, monitoring and management, nutrition and dietary education and assistance, medication administration oversight and management and including all routes of administration; health care services for oxygen and nebulizer treatments, physical, occupational and speech and language therapy services, ongoing physical and mental status assessment, mood, depression and safety assessment; health care services, namely, nursing case management and treatment coordination with all members of client's health care team and providers; health care services, namely, geriatric care; home health care services for immobile and/or homebound individuals whether transitionally or permanently homebound, anxiety and behavioral disorders care and management, post-surgical care and post-traumatic care, including any new or recent fractures, as well as status-post joint replacements such as hip or knee surgery or as a result of disease process or traumatic injuries; health care services, namely, client and caregiver education as well as ongoing evaluation and assessment of the effect of client/caregiver teaching; home health care services; home health care services, for home adult care, including assistance with all activities of daily living, infusion therapy services, phlebotomy services, all ostomy care, enteral nutrition services, blood glucose monitoring, wound care, from basic wound care to negative pressure wound care treatment and use of smart dressings to facilitate wound healing; home health care services for pain assessment, client monitoring and management, nutrition and dietary education and assistance, medication administration oversight and management and including all routes of administration; home health care services for oxygen and nebulizer treatments, physical, occupational and speech and language therapy services, ongoing physical and mental status assessment, mood, depression and safety assessment; home health care services, namely, nursing case management and treatment coordination with all members of the client's health care team and providers, home health care services, namely, geriatric care and services;, home health care services for the immobile and/or homebound client whether transitionally or permanently homebound; home health care services for anxiety and behavioral disorders care and management, post-surgical care and post-traumatic care, including any new or recent fractures, as well as status-post joint replacements such as hip or knee surgery or as a result of disease process or traumatic injuries; home health care services for client and caregiver education as well as ongoing evaluation and assessment of the effect of client/caregiver teachingSECTION 8 - CANCELLEDDec 31, 2005

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 10, 2023C8..CANCELLED SEC. 8 (6-YR)—
Aug 23, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 1, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 23, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 20, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED—
Jul 19, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 15, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 15, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 20, 2016IUAFUSE AMENDMENT FILED—
Jun 20, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 12, 2016NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 28, 2015NPUBNOTICE OF PUBLICATION—
Oct 10, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 9, 2015ALIEASSIGNED TO LIE—
Sep 10, 2015CNEAEXAMINERS AMENDMENT MAILED—
Sep 10, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 10, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Sep 10, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 18, 2015CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2015DOCKASSIGNED TO EXAMINER—
May 16, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 11, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance